{"entity":{"id":"sonja-optendrenk","kind":"person","name":"Sonja Optendrenk","aka":[],"tldr":"Impartial chair of Germany's Federal Joint Committee (G-BA), the body that decides which treatments statutory health insurance covers.","summary":"Dr. Sonja Optendrenk is the impartial chair of the Gemeinsamer Bundesausschuss (G-BA), Germany's highest decision-making body in statutory health insurance. The G-BA determines benefit coverage and commissions assessments, including early benefit assessments of new cancer drugs under AMNOG, from IQWiG. Her role is regulatory and policy leadership rather than clinical research.","asOf":"2026-09-10","links":[{"label":"Institution profile","url":"https://www.g-ba.de/ueber-den-gba/wer-wir-sind/mitglieder/"}],"tags":["leadership","regulation","health technology assessment"],"related":[],"cancers":[],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":["g-ba-iqwig"],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"role":"Impartial Chair (Unparteiische Vorsitzende), Gemeinsamer Bundesausschuss","institutionId":"g-ba-iqwig","specialisms":["Health policy","Statutory health insurance benefits","Health technology assessment"],"profiles":[{"label":"Institution profile","url":"https://www.g-ba.de/ueber-den-gba/wer-wir-sind/mitglieder/"}],"papers":[],"papersExpected":false},"route":"/people/sonja-optendrenk/","neighbours":{"institution":[{"id":"g-ba-iqwig","kind":"institution","name":"Gemeinsamer Bundesausschuss / IQWiG","route":"/institutions/g-ba-iqwig/"}]}}